<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">Problems of Social Hygiene, Public Health and History of Medicine</journal-id><journal-title-group><journal-title>Problems of Social Hygiene, Public Health and History of Medicine</journal-title></journal-title-group><issn publication-format="print">0869-866X</issn><issn publication-format="electronic">2412-2106</issn><publisher><publisher-name>Joint-Stock Company Chicot</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">683</article-id><article-id pub-id-type="doi">10.32687/0869-866X-2021-29-5-1047-1056</article-id><article-categories><subj-group subj-group-type="heading"><subject>Научная статья</subject></subj-group></article-categories><title-group><article-title>The social demographic aspects of vaccination of population of Russia in the context of COVID-19 pandemic</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Ryazantsev</surname><given-names>S. V.</given-names></name><bio></bio><email>riazan@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Khramova</surname><given-names>M. N.</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Smirnov</surname><given-names>A. V.</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff id="aff-1">The Institute for Demographic Research of the Federal Research Sociological Center of The Russian Academy of Sciences</aff><pub-date date-type="epub" iso-8601-date="2021-10-15" publication-format="electronic"><day>15</day><month>10</month><year>2021</year></pub-date><volume>29</volume><issue>5</issue><fpage>1047</fpage><lpage>1056</lpage><history><pub-date date-type="received" iso-8601-date="2021-10-22"><day>22</day><month>10</month><year>2021</year></pub-date></history><permissions><copyright-statement>Copyright © 2021,</copyright-statement><copyright-year>2021</copyright-year></permissions><abstract>The pandemic of the new corona-virus infection COVID-19 will be over only when population immunity will be developed. This condition can be achieved by both vaccination and surviving disease in natural way. The WHO recommends the first mode for achieving population immunity, since immune response to vaccine is similar to that one developed while surviving natural infection, but with minimal risks to health and life. The article presents the results of sociological survey organized with purpose of studying the attitude of Russians to vaccination against COVID-19 infection. The results of the survey demonstrated that at present, 22% of respondents are ready to be vaccinated i.e. they responded positively to the corresponding question. The following main factors determining population attitude to vaccination were identified. First, there is statistically significant correlation between vaccination readiness and education level: respondents with higher level of education are more likely to be vaccinated against COVID-19. Secondly, in general, the population is quite positive about the response of the National health care to the corona-virus pandemic. However, the percentage of population that is positive about vaccination can be higher if it would be possible to apply foreign-made vaccines in Russia. Thirdly, still there is large percentage of population believing that vaccination with medications that have not passed long-term clinical trials can result in health negative consequences. Fourthly, the majority of respondents experienced various manifestations of the pandemic on themselves: either they have been ill themselves, or their relatives and friends were ill or died and almost all of them somehow limited their common mobility.The survey results did not established statistically significant differences in distribution of responses among males and females. We assume that in order to develop positive attitude of population to vaccination, and specifically to Russian-made vaccines, more extensive information campaign is needed to be implemented. Also, significant increase of percentage of vaccinated population can be achieved if clearly defined requirements for availability of COVID-19 vaccination would be adopted on the international level. Actually, this is key condition for restoring international mobility and removing restrictions in national economies.</abstract><kwd-group xml:lang="en"><kwd>COVID-19</kwd><kwd>pandemic</kwd><kwd>vaccination</kwd><kwd>population</kwd><kwd>population immunity</kwd><kwd>Sputnik V vaccine</kwd><kwd>restrictive measures in economy</kwd><kwd>population attitudes to vaccination</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>пандемия COVID-19</kwd><kwd>вакцинация населения</kwd><kwd>популяционный иммунитет</kwd><kwd>вакцина «Спутник V»</kwd><kwd>отношение населения к вакцинации</kwd><kwd>ограничительные меры в экономике</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>В России стартовала массовая вакцинация от коронавируса. Режим доступа: https://ria.ru/20210118/vaktsinatsiya-1593436428.html (дата обращения 01.04.2021).</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>В России для производства вакцин от COVID-19 задействовали все мощности. Режим доступа: https://ria.ru/20210218/vaktsina-1597991942.html (дата обращения 01.04.2021).</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Статистика вакцинации от коронавируса. Режим доступа: https://gogov.ru/articles/covid-v-stats (дата обращения 01.04.2021).</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Еврокомиссия объявила о начале третьей волны пандемии коронавируса в Европе. Режим доступа: https://tass.ru/obschestvo/10948645 (дата обращения 01.04.2021).</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Десять проблем здравоохранения, над которыми ВОЗ будет работать в 2019 году. Режим доступа: https://www.who.int/ru/news-room/spotlight/ten-threats-to-global-health-in-2019 (дата обращения 11.03.2021).</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>CDC statistics demonstrate dramatic declines in vaccine-preventable diseases when compared with the pre-vaccine era. Режим доступа: https://www.immunize.org/nslt.d/n62/vaccines_work.pdf (дата обращения 11.03.2021).</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Chinese Smallpox Inoculation. Режим доступа: https://www.historyofvaccines.org/content/early-chinese-inoculation (дата обращения 13.03.2021).</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Boylston A. The origins of inoculation. J. Royal Soc. Med. 2012;105(7):309-13.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Корь. Режим доступа: https://www.who.int/ru/news-room/fact-sheets/detail/measles (дата обращения 13.03.2021).</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Vaccines and immunization: Myths and misconceptions. Режим доступа: https://www.who.int/news-room/q-a-detail/vaccines-and-immunization-myths-and-misconceptions (дата обращения 13.03.2021).</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>History of Anti-vaccination Movements. Режим доступа: https://www.historyofvaccines.org/content/articles/history-anti-vaccination-movements (дата обращения 13.03.2021).</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Wolfe R., Sharp L. Anti-vaccinationists past and present. BMJ. 2002;325:430-2.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Недоверие к вакцинации: растущая проблема для программ иммунизации. Режим доступа: https://www.who.int/ru/news/item/18-08-2015-vaccine-hesitancy-a-growing-challenge-for-immunization-programmes (дата обращения 13.03.2021).</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Worldwide measles deaths climb 50% from 2016 to 2019 claiming over 207 500 lives in 2019. Режим доступа: https://www.who.int/news/item/12-11-2020-worldwide-measles-deaths-climb-50-from-2016-to-2019-claiming-over-207-500-lives-in-2019 (дата обращения 13.03.2021).</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Study: vaccines prevent not just disease, but also poverty. Режим доступа: https://www.gavi.org/news/media-room/study-vaccines-prevent-not-just-disease-also-poverty (дата обращения 13.03.2021).</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Хронология действий ВОЗ по борьбе с COVID-19. Режим доступа: https://www.who.int/ru/news/item/29-06-2020-covidtimeline (дата обращения 13.03.2021).</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). Режим доступа: https://www.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6 (дата обращения 13.03.2021).</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Number of military fatalities in all major wars involving the United States from 1775 to 2021. Режим доступа: https://www.statista.com/statistics/1009819/total-us-military-fatalities-in-american-wars-1775-present/(дата обращения 13.03.2021).</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Risk for COVID-19 Infection, Hospitalization, and Death By Race/Ethnicity. Режим доступа: https://www.cdc.gov/coronavirus/2019-ncov/downloads/covid-data/hospitalization-death-by-race-ethnicity.pdf (дата обращения 13.03.2021).</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>COVID-19 likely ranks as the third leading cause of death in the US in 2020, CDC statisticians say. Режим доступа: https://edition.cnn.com/2021/01/05/health/covid-third-leading-cause-of-death-cdc-wellness/index.html (дата обращения 13.03.2021).</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Путин сравнил успехи России и западных стран в борьбе с коронавирусом. Режим доступа: https://www.rbc.ru/rbcfreenews/60286aa89a794738cded2af5 (дата обращения 13.03.2021).</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Logunov D. Y., Dolzhikova I. V., Shcheblyakov V. D. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet. 2021;397:671-81.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Вопросы и ответы: коллективный иммунитет, меры самоизоляции и COVID-19. Режим доступа: https://www.who.int/ru/news-room/q-a-detail/herd-immunity-lockdowns-and-COVID-19 (дата обращения 13.03.2021).</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Antibodies, Immunity, and COVID-19. Режим доступа: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2773575 (дата обращения 13.03.2021).</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Wooldridge J. M. Intriductory Econometrics. A Modern Approach. 6th ed. Cengage Learning; 2016.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Об итогах эпидемического сезона гриппа 2018-2019. Официальный сайт Роспотребнадзора. Режим доступа: https://www.rospotrebnadzor.ru/about/info/news/news_details.php?ELEMENT_ID=12661&amp;sphrase_id=3244611 (дата обращения 09.04.2021).</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Пандемия COVID-19: Вызовы, последствия, противодействие: Монография. Под ред. А. В. Торкунова, С. В. Рязанцева, В. К. Левашова. М.: Издательство «Аспект Пресс»; 2021. 248 с.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>В Роспотребнадзоре назвали долю россиян с иммунитетом к коронавируса. Режим доступа: https://www.rbc.ru/rbcfreenews/603be6e19a794721b7afb88c (дата обращения 18.03.2021).</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Собянин назвал долю переболевших коронавирусом москвичей. Режим доступа: https://www.rbc.ru/society/29/01/2021/601450b29a79476fce1a4d87 (дата обращения 18.03.2021).</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Коронавирус: официальная информация. Режим доступа: https://www.mos.ru/city/projects/COVID-19/(дата обращения 18.03.2021).</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Названа реальная численность населения Москвы. Режим доступа: https://www.mos.ru/dvms/documents/materialy_smi/view/228778220/(дата обращения 18.03.2021).</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Мурашко назвал сроки появления коллективного иммунитета к COVID у россиян. Режим доступа: https://www.rbc.ru/society/20/01/2021/600817709a794793286a733b (дата обращения 18.03.2021).</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>ВОЗ: чтобы остановить коронавирус, необходима вакцинация 60-70% населения мира. Режим доступа: https://tass.ru/obschestvo/10118633 (дата обращения 18.03.2021).</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Источники не ждут поставок вакцины Pfizer в Россию в 2021 году. Режим доступа: https://www.interfax.ru/russia/744764 (дата обращения 18.03.2021).</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Росздравнадзор заявил о незаконности применения вакцины Pfizer до регистрации. Режим доступа: https://www.interfax.ru/russia/745091 (дата обращения 18.03.2021).</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Главные вопросы к скандалу вокруг вакцины AstraZeneca. Режим доступа: https://www.rbc.ru/business/16/03/2021/6050b40b9a794715f85f4466 (дата обращения 09.04.2021).</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Forecasted monetary global GDP loss due to COVID-19 , by scenario 2020. Режим доступа: https://www.statista.com/statistics/1102971/COVID-19-monetary-global-gdp-loss-scenario/(дата обращения 18.03.2021).</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Coronavirus COVID-19 in China - statistics &amp; facts. Режим доступа: https://www.statista.com/topics/5898/novel-coronavirus-COVID-19-in-china/(дата обращения 18.03.2021).</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>China’s Growth Beats Estimates as Economy Powers Out of Covid. Режим доступа: https://www.bloomberg.com/news/articles/2021-01-18/china-s-economy-grew-2-3-in-2020-accelerating-global-rise (дата обращения 18.03.2021).</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Projected coronavirus (COVID-19) impact index by industry and dimension - minor (1) to severe (5) in 2020. Режим доступа: https://www.statista.com/statistics/1106302/coronavirus-impact-index-by-industry-2020/(дата обращения 18.03.2021).</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Coronavirus (COVID-19) Vaccinations. Режим доступа: https://ourworldindata.org/covid-vaccinations (дата обращения 18.03.2021).</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>В бар по вакцинному паспорту. Как Израиль может стать моделью будущего мироустройства. Режим доступа: https://www.bbc.com/russian/features-56337608 (дата обращения 18.03.2021).</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>ВОЗ: богатые страны скупают вакцины, остальные могут остаться за бортом. Режим доступа: https://news.un.org/ru/story/2021/01/1393852 (дата обращения 18.03.2021).</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Глобальный механизм по обеспечению доступности вакцин против COVID-19 объединяет 172 страны и работает над несколькими перспективными вакцинами. Режим доступа: https://www.who.int/ru/news/item/24-08-2020-172-countries-and-multiple-candidate-vaccines-engaged-in-COVID-19-vaccine-global-access-facility (дата обращения 18.03.2021).</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>The Gavi COVAX AMC Explained. Режим доступа: https://www.gavi.org/vaccineswork/gavi-covax-amc-explained (дата обращения 21.03.2021).</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Rich nations vaccinating one person every second while majority of the poorest nations are yet to give a single dose. Режим доступа: https://www.unaids.org/en/resources/presscentre/featurestories/2021/march/20210310_covid19-vaccines (дата обращения 18.03.2021).</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Президент Аргентины связал критику «Спутника V» с геополитической борьбой. Режим доступа: https://tass.ru/mezhdunarodnaya-panorama/10373173 (дата обращения 01.04.2021).</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Глава МИД Венгрии заявил о нападках ЕС из-за вакцины «Спутник V». Режим доступа: https://www.rbc.ru/rbcfreenews/605769ab9a794715ad2a8f5a (дата обращения 01.04.2021).</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Канцлер Австрии назвал сроки заказа у России вакцины «Спутник V». Режим доступа: https://www.rbc.ru/politics/31/03/2021/60647e289a794711b323fcca (дата обращения 01.04.2021).</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Премьер-министр: Литва не будет использовать российскую вакцину Sputnik V. Режим доступа: https://www.lrt.lt/ru/novosti/17/1339749/prem-er-ministr-litva-ne-budet-ispol-zovat-rossiiskuiu-vaktsinu-sputnik-v (дата обращения 01.04.2021).</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Саммит «Группы двадцати». Режим доступа: http://kremlin.ru/events/president/news/64460 (дата обращения 01.04.2021).</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Sputnik V worldwide in October 2020, by country. Режим доступа: https://www.statista.com/statistics/1188830/sputnik-v-awareness-worldwide-by-country/(дата обращения 01.04.2021).</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Number of doses of the COVID-19 vaccine Sputnik V ordered from Russia or agreed to be produced abroad as of March 29, 2021, by country. Режим доступа: https://www.statista.com/statistics/1123927/sputnik-v-exports-from-russia-by-country/(дата обращения 01.04.2021).</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>Вакцина «Спутник V» получила одобрение в 50-й стране. Режим доступа: https://rdif.ru/fullNews/6519/(дата обращения 21.03.2021).</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>Источник назвал возможные сроки допуска «Спутник V» в Евросоюз. Режим доступа: https://ria.ru/20210319/vaktsina-1601975451.html (дата обращения 23.03.2021).</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation>Европейское агентство лекарственных средств начало процедуру последовательной экспертизы регистрационного досье вакцины «Спутник V». Режим доступа: https://rdif.ru/fullNews/6494/(дата обращения 21.03.2021).</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation>Канцлер Австрии призвал ускорить регистрацию «Спутника V» в Европе. Режим доступа: https://www.rbc.ru/society/18/03/2021/605277999a79472d9bb84bdf (дата обращения 21.03.2021).</mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation>Меркель допустила закупку «Спутника V» Германией в обход Евросоюза. Режим доступа: https://www.rbc.ru/society/19/03/2021/6054f4d29a794715fe44a1d8 (дата обращения 21.03.2021).</mixed-citation></ref></ref-list></back></article>
